For: | Kang BW, Kim JG, Kwon OK, Chung HY, Yu W. Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan. World J Gastroenterol 2014; 20(18): 5396-5402 [PMID: 24833869 DOI: 10.3748/wjg.v20.i18.5396] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i18/5396.htm |
Number | Citing Articles |
1 |
Hatice YILDIRIM, Ayşe Tuğşen AYDEMİR. Multidrug resistance gene expression response to cisplatin and 5FU treatment in hepatoma, prostate and colon cancer cells. Balıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2020; 22(2): 698 doi: 10.25092/baunfbed.757286
|
2 |
Xinyu Gu, Shuang Li, Xiao Ma, Di Huang, Penghui Li. Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1252805
|
3 |
Mi Yea Lee, Min-Jee Kim, Jun-O Jin, Peter Chang-Whan Lee. USP14 inhibition regulates tumorigenesis by inducing apoptosis in gastric cancer. BMB Reports 2023; 56(8): 451 doi: 10.5483/BMBRep.2023-0063
|
4 |
FEI YUAN, HAILONG SHI, JUN JI, QU CAI, XUEHUA CHEN, YINGYAN YU, BINGYA LIU, ZHENGGANG ZHU, JUN ZHANG. Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis. Oncology Reports 2015; 33(4): 1753 doi: 10.3892/or.2015.3765
|
5 |
Qian Liu, Lijuan Guo, Zhiyuan Lou, Xueping Xiang, Jimin Shao. Super-enhancers and novel therapeutic targets in colorectal cancer. Cell Death & Disease 2022; 13(3) doi: 10.1038/s41419-022-04673-4
|
6 |
Jie Ge, Ting Liu, Tianxiang Lei, Xuan Li, Kun Song, Samim Azizi, Heli Liu, Mimi Tang. Retrospective Cohort Study of Intraoperative Administration of Sustained-Release 5-Fluorouracil Implants in Advanced Gastric Cancer Patients. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.659258
|
7 |
Kuo Kang, Xuanxuan Li, Yuanhao Peng, Yangying Zhou. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer. Biomedicines 2023; 11(12): 3165 doi: 10.3390/biomedicines11123165
|
8 |
MASAHIRO INOUE, KAZUNORI OTSUKA, HIROYUKI SHIBATA. Circulating tumor cell count as a biomarker of a specific gastric cancer subgroup characterized by bone metastasis and/or disseminated intravascular coagulation - an early indicator of chemotherapeutic response. Oncology Letters 2016; 11(2): 1294 doi: 10.3892/ol.2015.4056
|
9 |
Nayla Mouawad, Maguie El Boustani, Vincenzo Canzonieri, Isabella Caligiuri, Flavio Rizzolio. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 213 doi: 10.1007/978-3-030-04861-7_13
|
10 |
Nebojša Đ. Pantelić, Bojan Božić, Bojana B. Zmejkovski, Nebojša R. Banjac, Biljana Dojčinović, Ludger A. Wessjohann, Goran N. Kaluđerović. In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines. Molecules 2021; 26(11): 3199 doi: 10.3390/molecules26113199
|
11 |
Tingting Zhao, Zhi Xu, Dongying Gu, Peng Wu, Xinying Huo, Xiaowei Wei, Yongfei Tang, Weida Gong, Ming-Liang He, Jinfei Chen. The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy. Scientific Reports 2016; 6(1) doi: 10.1038/srep28019
|
12 |
Afzal Hussain, Mohamed Fahad AlAjmi, Prince F. Iqbal, Waseem A. Wani. Combination Therapy Against Multidrug Resistance. 2020; : 95 doi: 10.1016/B978-0-12-820576-1.00005-9
|